COO in ADDvise Group AB, Erland Pontusson, retires but remains in the group as Senior Advisor - Regulatory information

06-03-2020   Regulatory press release

Erland Pontusson, COO and member of the management team in ADDvise Group AB, will be retiring on 30 June 2020 in connection with his 67th birthday. Erland Pontusson will thereafter remain in the group as “Senior Advisor”. In addition, Erland Pontusson has also been proposed, by the nomination committee of the annual general meeting 2020, to be elected as a new member of the board of directors of ADDvise Group AB.  

After 30 June 2020, the work performed by Erland Pontusson as the COO will initially be taken over by existing positions within ADDvise Group AB.  

Erland Pontusson commenced his employment as business area manager in ADDvise and took over as COO in 2016. Erland Pontusson has during his time with the company project managed and completed a various of operations which have contributed to the development and growth of the group.    

Rikard Akhtarzand, CEO, ADDvise Group AB:

“I would like to thank Erland for his efforts during his five years working with ADDvise. Erland has been essential in the work of decentralizing the group and to increase our subsidiaries’ independency. Erland has also made great efforts in terms of improving the relationships with our material customers. I am looking forward to continue the cooperation with Erland as a Senior Advisor and board member in ADDvise Group.”  

For further information, please contact:

Rikard Akhtarzand, CEO
+46 765-25 90 71

Important information:

This information is by ADDvise Group AB required to disclose under the EU Market Abuse Regulation. The information was submitted for publication on 6 March 2020 at 16.30 CET.

About ADDvise Group

ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The group consists of approximately 10 subsidiaries organized into two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expand the business – both geographically and product wise. ADDvise Group’s shares are listed on Nasdaq First North Growth Market and Mangold Fondkommission AB, +46 8 503 015 50,, is the Company's Certified Adviser. Additional information is available at


Latest press releases

ADDvise announces preliminary result for 2022 which is stronger than expected


The preliminary result for ADDvise Group for the full year 2022 significantly deviates from what ADDvise Group considers to be current market expectations. [image] The net sales pro forma full year 2022 rolling 12 months amounted to SEK 1,097 million with an adjusted EBITDA pro forma of SEK 241 million. The financial targets for the…

ADDvise receives order worth USD 3.5 million


ADDvise Group AB’s subsidiary Poly Pharmaceuticals Inc has received an order from AxisCare Health Logistics Inc, a company distributing equipment and medical supplies to hospitals, clinics, medical offices and medical equipment suppliers. The order is worth approximately USD 3.5 million. The order consists of delivery of the prescription dietary supplemental Folite, developed and manufactured by…

ADDvise receives order worth USD 1.8 million


ADDvise Group AB’s subsidiary MRC Systems FZE has received an order from Nasser Saeed Al Hajri & Partners Contracting (NHS & Partners), a leading construction contractor in the United Arab Emirates. The order is worth approximately USD 1.8 million. The order involves the detailed design, supply and installation of an ISO 8 and ISO 7…